Stefano Cascinu

机构：Vita-Salute San Raffaele University, Istituti di Ricovero e Cura a Carattere Scientifico · ORCID：0000-0003-2215-0731

发表论文 1594 篇 · 总被引 30976 次 · h-index 81

代表论文

• Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: An early exploratory analysis of real‐world data (2023 · Liver International · 被引 123)
• Sequential therapies after atezolizumab plus bevacizumab or lenvatinib first-line treatments in hepatocellular carcinoma patients (2023 · European Journal of Cancer · 被引 59)
• Disease Etiology Impact on Outcomes of Hepatocellular Carcinoma Patients Treated with Atezolizumab plus Bevacizumab: A Real-World, Multicenter Study (2024 · Liver Cancer · 被引 29)
• Durvalumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Biliary Tract Cancer: a Real-World Retrospective, Multicenter Study (2024 · Targeted Oncology · 被引 28)
• International consensus on the management of metastatic gastric cancer: step by step in the foggy landscape (2024 · Gastric Cancer · 被引 26)
• Oncotype DX results increase concordance in adjuvant chemotherapy recommendations for early-stage breast cancer (2023 · npj Breast Cancer · 被引 19)